AGP Picks
View all

Catch up with science and technology news from Haiti

Provided by AGP

Haiti, Science, & Me: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Haiti, Science, & Me.

Press releases published on May 14, 2026

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission
Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase
Orbit International Corp. Reports 2026 First Quarter Results
AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer
Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
Gov. Moore Signs Maryland Digital Asset Task Force and Blockchain Property-Records Bills Into Law
GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline
Biogen Completes Acquisition of Apellis Pharmaceuticals
Helport AI Launches New ‘AI Labor’ Corporate Website
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
Phunware Appoints Dmitry Kroshka as Chief Executive Officer to Lead 2.0 Strategy; Engages Michael Cerdá to Drive Product Rollout
Biodexa issues letter to Shareholders
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Exol Announces Strategic Partnership with Manhattan Associates to Unify and Transform Supply Chain Execution
FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
Live Ventures Reports Fiscal Second Quarter 2026 Financial Results
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
Forge Nano Delivers Semiconductor Wafer Fab Equipment to Leading Fortune Global 500 Communications Company for Commercial Photonics Applications

Share us

on your social networks:

Sign up for:

Haiti, Science, & Me

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.